BSE Live
Oct 08, 16:01Prev. Close
348.05
Open Price
346.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 08, 15:58Prev. Close
347.80
Open Price
346.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
349.00 (539)
Balance Sheet of Biocon (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Total Share Capital | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Reserves and Surplus | 2,483.50 | 2,316.80 | 2,105.90 | 1,995.50 | 1,845.90 | |
Total Reserves and Surplus | 2,484.40 | 2,317.70 | 2,106.80 | 1,996.40 | 1,846.80 | |
Total Shareholders Funds | 2,584.40 | 2,417.70 | 2,206.80 | 2,096.40 | 1,946.80 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 11.40 | 25.90 | 40.00 | 60.50 | 65.80 | |
Deferred Tax Liabilities [Net] | 36.80 | 40.00 | 30.20 | 34.90 | 39.60 | |
Other Long Term Liabilities | 136.40 | 131.10 | 108.30 | 64.90 | 69.50 | |
Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 184.60 | 197.00 | 178.50 | 160.30 | 174.90 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 56.10 | 81.50 | 77.30 | 86.80 | 96.30 | |
Trade Payables | 300.80 | 268.50 | 265.00 | 251.10 | 199.70 | |
Other Current Liabilities | 60.30 | 89.90 | 67.90 | 76.90 | 57.10 | |
Short Term Provisions | 146.80 | 163.90 | 217.70 | 148.80 | 128.70 | |
Total Current Liabilities | 564.00 | 603.80 | 627.90 | 563.60 | 481.80 | |
Total Capital And Liabilities | 3,333.00 | 3,218.50 | 3,013.20 | 2,820.30 | 2,603.50 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 898.60 | 941.00 | 845.50 | 675.70 | 666.20 | |
Intangible Assets | 15.70 | 8.30 | 5.90 | 9.30 | 13.40 | |
Capital Work-In-Progress | 57.60 | 101.80 | 51.20 | 82.50 | 102.70 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 971.90 | 1,051.10 | 902.60 | 767.50 | 782.30 | |
Non-Current Investments | 80.40 | 144.90 | 166.00 | 166.40 | 92.00 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 543.50 | 554.60 | 471.30 | 534.30 | 416.20 | |
Other Non-Current Assets | 1.30 | 0.60 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Assets | 1,597.10 | 1,751.20 | 1,539.90 | 1,468.20 | 1,290.50 | |
CURRENT ASSETS | ||||||
Current Investments | 84.30 | 348.30 | 453.00 | 490.60 | 393.90 | |
Inventories | 406.30 | 357.60 | 358.90 | 340.40 | 274.70 | |
Trade Receivables | 555.10 | 494.60 | 427.00 | 445.00 | 418.10 | |
Cash And Cash Equivalents | 621.20 | 204.20 | 179.20 | 40.00 | 210.30 | |
Short Term Loans And Advances | 55.20 | 56.80 | 51.00 | 30.20 | 16.00 | |
OtherCurrentAssets | 13.80 | 5.80 | 4.20 | 5.90 | 0.00 | |
Total Current Assets | 1,735.90 | 1,467.30 | 1,473.30 | 1,352.10 | 1,313.00 | |
Total Assets | 3,333.00 | 3,218.50 | 3,013.20 | 2,820.30 | 2,603.50 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 1,228.40 | 829.50 | 476.40 | 285.40 | 201.90 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 533.70 | 523.90 | 491.70 | 383.30 | 382.20 | |
Stores, Spares And Loose Tools | 62.50 | 65.50 | 17.70 | 19.30 | 4.50 | |
Trade/Other Goods | 62.50 | 65.50 | 17.70 | 19.30 | 4.50 | |
Capital Goods | 13.50 | 61.30 | 16.80 | 41.10 | 50.20 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 105.70 | 82.30 | 54.20 | 77.60 | 33.70 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | 21.20 | 31.90 | 21.30 | 19.20 | 14.50 | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 1,033.90 | 1,066.90 | 944.90 | 666.10 | 524.40 | |
Other Earnings | 65.40 | 13.40 | 45.60 | 11.20 | 169.10 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 93.47 | 93.47 | 93.47 | 93.47 | 93.47 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | 159.90 | 117.60 | 97.80 | 153.80 | |
Non-Current Investments Unquoted Book Value | 80.40 | 102.20 | 123.20 | 137.10 | 66.00 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | 84.30 | 348.30 | 453.00 | 490.60 | 393.90 |
18.09.2025
18.09.2025
11.09.2025
05.09.2025
19.08.2025
Biocon Standalone June 2025 Net Sales at Rs 537.10 crore, up 5.19% Y-o-Y
08.05.2025
Biocon Consolidated March 2025 Net Sales at Rs 4,417.00 crore, up 12.76% Y-o-Y
08.05.2025
Biocon Standalone March 2025 Net Sales at Rs 643.80 crore, up 20.88% Y-o-Y
31.01.2025
Biocon Consolidated December 2024 Net Sales at Rs 3,821.40 crore, down 3.35% Y-o-Y